“The Twelve Traditions | Alcoholics Anonymous.” The Twelve Traditions | Alcoholics Anonymous, www.aa.org/the-twelve-traditions.
Borkman, Thomasina. “The Twelve-Step Recovery Model of AA: A Voluntary Mutual Help Association.” Recent Developments in Alcoholism, Springer New York, 2008, pp. 9–35. Crossref, https://doi.org/10.1007/978-0-387-77725-2_2.
Kaskutas, Lee Ann. “Alcoholics Anonymous Effectiveness: Faith Meets Science.” Journal of Addictive Diseases, vol. 28, no. 2, Informa UK Limited, Apr. 2009, pp. 145–57. Crossref, https://doi.org/10.1080/10550880902772464.
Ippulito, Tracy A. “Safe in the Rooms of AA: How Anonymity Helps Reduce the Stigma of Help-seeking and Reinforces Solidarity and Group Cohesiveness.” Alcoholism Treatment Quarterly, vol. 38, no. 1, Informa UK Limited, July 2019, pp. 2–20. Crossref, https://doi.org/10.1080/07347324.2019.1647772.
Zohar, Asaf, and Thomasina Borkman. “Emergent Order and Self-Organization: A Case Study of Alcoholics Anonymous.” Nonprofit and Voluntary Sector Quarterly, vol. 26, no. 4, SAGE Publications, Dec. 1997, pp. 527–52. Crossref, https://doi.org/10.1177/0899764097264008.
“The Twelve Steps | Alcoholics Anonymous.” The Twelve Steps | Alcoholics Anonymous, www.aa.org/the-twelve-steps.
Fiorentine, Robert, and Maureen P. Hillhouse. “Drug Treatment and 12-step Program Participation.” Journal of Substance Abuse Treatment, vol. 18, no. 1, Elsevier BV, Jan. 2000, pp. 65–74. Crossref, https://doi.org/10.1016/s0740-5472(99)00020-3.
Kelly, John F., et al. “Alcoholics Anonymous and Other 12-step Programs for Alcohol Use Disorder.” Cochrane Database of Systematic Reviews, Wiley, Mar. 2020. Crossref, https://doi.org/10.1002/14651858.cd012880.pub2.
Mental Health Services Administration (US), Substance Abuse and Office of the Surgeon General (US). “Early Intervention, Treatment, and Management of Substance Use Disorders” – Facing Addiction in America – NCBI Bookshelf, 1 Nov. 2016, www.ncbi.nlm.nih.gov/books/NBK424859.
Substance Abuse Treatment, Center for. “Chapter 5—Specialized Substance Abuse Treatment Programs – a Guide to Substance Abuse Services for Primary Care Clinicians – NCBI Bookshelf.” Chapter 5—Specialized Substance Abuse Treatment Programs – a Guide to Substance Abuse Services for Primary Care Clinicians – NCBI Bookshelf, 1 Jan. 1997, www.ncbi.nlm.nih.gov/books/NBK64815.
Tonigan, J. Scott, et al. “Spirituality as a Change Mechanism in 12-Step Programs: A Replication, Extension, and Refinement.” Substance Use & Misuse, vol. 48, no. 12, Informa UK Limited, Sept. 2013, pp. 1161–73. Crossref, https://doi.org/10.3109/10826084.2013.808540.
Zemore, Sarah E., et al. “Comparison of 12-step Groups to Mutual Help Alternatives for AUD in a Large, National Study: Differences in Membership Characteristics and Group Participation, Cohesion, and Satisfaction.” Journal of Substance Abuse Treatment, vol. 73, Elsevier BV, Feb. 2017, pp. 16–26. Crossref, https://doi.org/10.1016/j.jsat.2016.10.004.
“Drug Overdose Death Rates | National Institute on Drug Abuse.” National Institute on Drug Abuse, 30 June 2023, nida.nih.gov/research-topics/trends-statistics/overdose-death-rates.
Luba, Rachel, et al. “Fentanyl Withdrawal: Understanding Symptom Severity and Exploring the Rule of Body Mass Index on Withdrawal Symptoms and Clearance.” Addiction, vol. 118, no. 4, Wiley, Dec. 2022, pp. 719–26. Crossref, https://doi.org/10.1111/add.16100.
“Chapter 3—Family Counseling Approaches – Substance Use Disorder Treatment and Family Therapy – NCBI Bookshelf.” Chapter 3—Family Counseling Approaches – Substance Use Disorder Treatment and Family Therapy – NCBI Bookshelf, 1 Jan. 2020, www.ncbi.nlm.nih.gov/books/NBK571088.
“Buprenorphine Use in the Emergency Department Safe for People Who Use Fentanyl.” National Institutes of Health (NIH), 10 Apr. 2023, www.nih.gov/news-events/nih-research-matters/buprenorphine-use-emergency-department-safe-people-who-use-fentanyl.
“Kratom | National Institute on Drug Abuse.” National Institute on Drug Abuse, 25 Mar. 2022, nida.nih.gov/research-topics/kratom.
“Multistate Outbreak of Salmonella I 4,[5],12:B:- Infections Linked to Kratom Products | February 2018 | Salmonella | CDC.” Multistate Outbreak of Salmonella I 4,[5],12:B:- Infections Linked to Kratom Products | February 2018 | Salmonella | CDC, 20 Feb. 2018, www.cdc.gov/salmonella/kratom-02-18.
Prevete, Elisabeth, et al. “A Systematic Review of (Pre)Clinical Studies on the Therapeutic Potential and Safety Profile of Kratom in Humans.” Human Psychopharmacology: Clinical and Experimental, vol. 37, no. 1, Wiley, July 2021. Crossref, https://doi.org/10.1002/hup.2805.
“Effective Treatments for Opioid Addiction | National Institute on Drug Abuse.” National Institute on Drug Abuse, 1 Nov. 2016, nida.nih.gov/publications/effective-treatments-opioid-addiction.
Settle, Austin G., and Chong Yang. “A Case of Severe Kratom Addiction Contributing to a Suicide Attempt.” Cureus, Cureus, Inc., Sept. 2022. Crossref, https://doi.org/10.7759/cureus.29698.